kristoff@GENBANK.BIO.NET (05/23/91)
$$MAIL BEGIN ***********************************************************
INDEX OF NIH GUIDE FOR GRANTS AND CONTRACTS
First Quarter of Calendar Year 1991 - January, February, March
Index word or phrase
TITLE OF ANNOUNCEMENT, RFA OR RFP (* = RFA, $ = RFP) Vol No Item
Academic Award
ACADEMIC AWARD IN ENVIRONMENTAL/OCCUPATIONAL MEDICINE 20, 09 P2
CLINICAL MENTAL HEALTH ACADEMIC AWARD 20, 13 P2
Academic Research Enhancement
ACADEMIC RESEARCH ENHANCEMENT AWARD 20, 04 P1
Aging/Gerontology
ALZHEIMER'S DISEASE AND RELATED CEREBRAL DEGENERATIVE DISORDERS *20, 03 R1
SITES TESTING OSTEOPOROSIS PREVENTION/INTERVENTION TREATMENTS *20, 03 R4
OSTEOPOROSIS PREVENTION/INTERVENTION TREATMENTS: PATHOPHYSIOL & *20, 03 R5
SPECIAL CARE UNITS FOR ALZHEIMER'S DISEASE *20, 04 R8
MINORITY DISSERTATION RESEARCH GRANTS IN AGING, 1991 *20, 07 R10
CLAUDE D. PEPPER OLDER AMERICANS INDEPENDENCE CENTERS *20, 07 R12
AIDS
MONONUCLEAR PHAGOCYTES IN OPPORTUNISTIC INFECTIONS OF ORAL MUCOSA $20, 02 R2
DEVELOPMENT OF MODELS FOR PEDIATRIC AIDS *20, 05 R4
PLACENTAL & PEDIATRIC METABOLISM, TOXICITY, & TRANSPORT OF anti-H *20, 05 R5
HIV IN MOTHERS AND INFANTS: IMMUNITY AND EARLY DIAGNOSIS *20, 05 R6
WORLD AIDS FOUNDATION 20, 07 N2
MECHANISMS OF HIV PATHOGENESIS IN PEDIATRIC POPULATIONS 20, 07 P1
WORLD AIDS FOUNDATION 20, 09 N1
TRIALS OF BEHAVIORAL STRATEGIES TO PREVENT FURTHER SPREAD OF HIV *20, 10 R7
INCREASE IN TRAINING FUNDS FOR FY 1991 20, 11 N1
Alcohol/Alcoholism
FACILITIES CONSTRUCTION PROJECTS: CENTERS FOR SUBSTANCE ABUSE RE *20, 12 R2
Alzheimer's Disease
ALZHEIMER'S DISEASE AND RELATED CEREBRAL DEGENERATIVE DISORDERS *20, 03 R1
MANAGEMENT OF ALZHEIMER'S DISEASE SYMPTOMS *20, 03 R2
SPECIAL CARE UNITS FOR ALZHEIMER'S DISEASE *20, 04 R8
DRUG DISCOVERY GROUPS TO TREAT COGNITIVE IMPAIRMENT WITH ALZHEIME *20, 09 R4
CLINICAL STUDIES TO TREAT COGNITIVE IMPAIRMENT IN ALZHEIMER'S DIS *20, 10 R6
Animal Breed. & Facil., Scientific
CONSTRUCTION OF MOUSE PRODUCTION FACILITIES *20, 11 R3
TRANSGENIC, CHIMERIC, AND IN VITRO MODELS OF KIDNEY DISEASES 20, 12 P1
Animal Care
ANIMAL WELFARE EDUCATION PROGRAM: SURGERY AND POST-SURGICAL CARE 20, 04 N4
Animal Welfare Education
ANIMAL WELFARE EDUCATION PROGRAM: SURGERY AND POST-SURGICAL CARE 20, 04 N4
Anti-HIV Drugs
PLACENTAL & PEDIATRIC METABOLISM, TOXICITY, & TRANSPORT OF anti-H *20, 05 R5
Anticarcinogens
ANALYSES AND PHYSIOLOGY OF ANTICARCINOGENS IN SOYBEANS *20, 03 R3
Antivirals
PLACENTAL & PEDIATRIC METABOLISM, TOXICITY, & TRANSPORT OF anti-H *20, 05 R5
COLLECTION AND TAXONOMY OF SHALLOW WATER MARINE ORGANISMS $20, 07 R4
HERPES SIMPLEX VIRUS IN PATHOGENESIS OF ORAL MUCOSITIS IN CANCER $20, 09 R2
Apnea Monitors
EVENT RECORDINGS OF HIGH RISK INFANTS ON APNEA MONITORS *20, 10 R3
Arthritis
NIAMS PROGRAM PROJECT GUIDELINES 20, 05 N4
Artificial Lung
ARTIFICIAL LUNG RESEARCH AND DEVELOPMENT $20, 02 R1
Behavioral Medicine
EXPLORATORY CENTERS FOR HEALTH BEHAVIOR RESEARCH WITH CHILDREN & *20, 09 R6
CLINICAL STUDIES TO TREAT COGNITIVE IMPAIRMENT IN ALZHEIMER'S DIS *20, 10 R6
CLINICAL INVESTIGATOR AWARD FOR RESEARCH ON SPECIAL POPULATIONS *20, 10 R13
DETERMINANTS OF PERMANENT TOOTH LOSS IN THE U.S.A. $20, 11 R1
SMALL GRANT PROGRAM 20, 12 P2
Behavioral/Social Studies/Service
MANAGEMENT OF ALZHEIMER'S DISEASE SYMPTOMS *20, 03 R2
MINORITY DRUG ABUSE PREVENTION RESEARCH CENTERS *20, 06 R8
EXPLORATORY CENTERS FOR HEALTH BEHAVIOR RESEARCH WITH CHILDREN & *20, 09 R6
TRIALS OF BEHAVIORAL STRATEGIES TO PREVENT FURTHER SPREAD OF HIV *20, 10 R7
Bioassay
MONONUCLEAR PHAGOCYTES IN OPPORTUNISTIC INFECTIONS OF ORAL MUCOSA $20, 02 R2
IMPROVED STRATEGIES FOR DIAGNOSIS OF LYME DISEASE *20, 06 R3
ROLE OF ENHANCED CELL PROLIFERATION IN CHEMICAL CARCINOGENESIS $20, 07 R2
Biological Markers
SUPERFUND HAZARDOUS SUBSTANCES BASIC RESEARCH PROGRAM *20, 11 R4
CORRECTION: SUPERFUND HAZARDOUS SUBSTANCES BASIC RESEARCH PROGRA 20, 12 E1
Biological Resources
HUMAN LIVER CELL CULTURE FACILITY $20, 06 R2
COLLECTION AND TAXONOMY OF SHALLOW WATER MARINE ORGANISMS $20, 07 R4
INTERSTITIAL CYSTITIS DATA BASE: CLINICAL CENTERS & DATA COORDIN *20, 13 R6
Biology, Cellular
MONONUCLEAR PHAGOCYTES IN OPPORTUNISTIC INFECTIONS OF ORAL MUCOSA $20, 02 R2
MULTICENTER COOPERATIVE AGREEMENT TO STUDY NEURAL TUBE DEFECTS IN *20, 05 R11
MOLECULAR ANALYSES OF RADIATION-INDUCED GENETIC DAMAGE *20, 07 R5
RESEARCH UNITS ON PELVIC INFLAMMATORY DISEASE AND ITS SEQUELAE *20, 10 R15
TRANSGENIC, CHIMERIC, AND IN VITRO MODELS OF KIDNEY DISEASES 20, 12 P1
KAPOSI'S SARCOMA: CELL CYCLE STUDIES OF VASCULAR CELLS *20, 13 R5
Biomed. Research Resources, Other
METHODS THAT REPLACE VERTEBRATES USED IN RESEARCH, OR THAT LESSEN 20, 02 P1
PHS POLICY ON DISTRIBUTION OF UNIQUE RES. RESOURCES PRODUCED WITH 20, 05 N7
Biomedical Research Training
NATIONAL RESEARCH SERVICE AWARD STIPEND INCREASE 20, 01 N1
INCREASED STIPENDS FOR APPOINTEES TO MINORITY ACCESS TO RESEARCH 20, 07 N1
PREDOCTORAL FELLOWSHIP AWARDS FOR MINORITY STUDENTS *20, 07 R6
MINORITY DISSERTATION RESEARCH GRANTS IN AGING, 1991 *20, 07 R10
MEDICAL INFORMATICS RESEARCH TRAINING *20, 09 R5
ACADEMIC AWARD IN ENVIRONMENTAL/OCCUPATIONAL MEDICINE 20, 09 P2
SHORT-TERM TRAINING FOR MEDICAL STUDENTS IN ENVIRONMENTAL/OCCUPAT 20, 09 P3
PREDOCTORAL FELLOWSHIP AWARDS FOR MINORITY STUDENTS 20, 09 E2
SHORT-TERM CLINICAL TRAINING GRANTS IN DIAGNOSIS & TREATMENT OF D *20, 10 R4
SHORT-TERM GRANTS TO TRAIN MEDICAL STUDENTS TO DIAGNOSE & TREAT D *20, 10 R5
INCREASE IN TRAINING FUNDS FOR FY 1991 20, 11 N1
NRSA INSTITUTIONAL TRAINING GRANTS IN MEDICAL REHABILITATION RESE *20, 13 R3
Biomedical Research, Multidiscipl
CLINICAL CORE CENTERS FOR ORAL HEALTH RESEARCH *20, 01 R1
RESEARCH CENTERS IN ORAL BIOLOGY *20, 02 R4
BASIC & CLINICAL RESEARCH ON URINARY BLADDER & PELVIC MUSCULATURE *20, 04 R5
CHILD HEALTH RESEARCH CENTERS *20, 04 R7
ACADEMIC RESEARCH ENHANCEMENT AWARD 20, 04 P1
KIDNEY AND UROLOGY RESEARCH CENTERS *20, 05 R9
MULTICENTER COOPERATIVE AGREEMENT TO STUDY NEURAL TUBE DEFECTS IN *20, 05 R11
IMPROVED STRATEGIES FOR DIAGNOSIS OF LYME DISEASE *20, 06 R3
MINORITY DRUG ABUSE PREVENTION RESEARCH CENTERS *20, 06 R8
MEDICAL INFORMATICS RESEARCH TRAINING *20, 09 R5
THE NCI OUTSTANDING INVESTIGATOR GRANT 20, 09 P1
MINORITY SCHOOL FACULTY DEVELOPMENT AWARD *20, 10 R14
SUPERFUND HAZARDOUS SUBSTANCES BASIC RESEARCH PROGRAM *20, 11 R4
SMALL GRANT PROGRAM 20, 12 P2
CORRECTION: SUPERFUND HAZARDOUS SUBSTANCES BASIC RESEARCH PROGRA 20, 12 E1
Biopolymers Mechanics & Dynamics
METHODS OF MOLECULAR MECHANICS AND DYNAMICS OF BIOPOLYMERS WORKSH 20, 04 N5
Biotechnology
BIOTECHNOLOGY RESEARCH TRAINING 20, 01 P2
Blood Diseases
POSTDOCTORAL FELLOWSHIPS AND SENIOR FELLOWSHIPS IN HEMATOLOGIC RE 20, 11 P2
GENE THERAPY STRATEGIES FOR TREATMENT OF COOLEY'S ANEMIA *20, 12 R3
Brain
ALZHEIMER'S DISEASE AND RELATED CEREBRAL DEGENERATIVE DISORDERS *20, 03 R1
Breast Milk
EFFECT OF SPECIFIC COMPONENTS OF HUMAN MILK ON THE NURSLING *20, 10 R11
Cancer in Rural Areas
PROMOTE APPLICATION OF STATE-OF-THE-ART CANCER MANAGEMENT IN RURA *20, 05 R8
Cancer/Carcinogenesis
ANALYSES AND PHYSIOLOGY OF ANTICARCINOGENS IN SOYBEANS *20, 03 R3
PROMOTE APPLICATION OF STATE-OF-THE-ART CANCER MANAGEMENT IN RURA *20, 05 R8
STIMULATE CORRELATIVE LABORATORY STUDIES & CLINICAL TRIAL IN RADI *20, 06 R4
ROLE OF ENHANCED CELL PROLIFERATION IN CHEMICAL CARCINOGENESIS $20, 07 R2
PREVENTION CLIN TRIALS USING INTERMED ENDPOINTS & MODULATION BY C *20, 07 R11
THE NCI OUTSTANDING INVESTIGATOR GRANT 20, 09 P1
CLINICAL TREATMENT AND CORRELATES OF UPPER GI CARCINOMA 20, 09 E1
CLINICAL INVESTIGATOR AWARD FOR RESEARCH ON SPECIAL POPULATIONS *20, 10 R13
MINORITY SCHOOL FACULTY DEVELOPMENT AWARD *20, 10 R14
KAPOSI'S SARCOMA: CELL CYCLE STUDIES OF VASCULAR CELLS *20, 13 R5
Cardiovascular Diseases
KAPOSI'S SARCOMA: CELL CYCLE STUDIES OF VASCULAR CELLS *20, 13 R5
Cell Cycle Studies
KAPOSI'S SARCOMA: CELL CYCLE STUDIES OF VASCULAR CELLS *20, 13 R5
Cell Lines
METHODS THAT REPLACE VERTEBRATES USED IN RESEARCH, OR THAT LESSEN 20, 02 P1
HUMAN LIVER CELL CULTURE FACILITY $20, 06 R2
TRANSGENIC, CHIMERIC, AND IN VITRO MODELS OF KIDNEY DISEASES 20, 12 P1
Cell Proliferation
ROLE OF ENHANCED CELL PROLIFERATION IN CHEMICAL CARCINOGENESIS $20, 07 R2
Centers
KIDNEY AND UROLOGY RESEARCH CENTERS *20, 05 R9
CHRONIC FATIGUE SYNDROME COOPERATIVE RESEARCH CENTERS *20, 06 R6
Centers, Core
CLINICAL CORE CENTERS FOR ORAL HEALTH RESEARCH *20, 01 R1
Centers, Research
RESEARCH CENTERS IN ORAL BIOLOGY *20, 02 R4
RESEARCH CENTER OF EXCELLENCE IN PEDIATRIC NEPHROLOGY AND UROLOGY *20, 04 R6
CHILD HEALTH RESEARCH CENTERS *20, 04 R7
Cerebrovascular Disorders
CEREBRAL MAGNETIC RESONANCE IMAGING TO EVALUATE STROKE RISK FACTO $20, 06 R1
Chemical Carcinogenesis
ROLE OF ENHANCED CELL PROLIFERATION IN CHEMICAL CARCINOGENESIS $20, 07 R2
Chemical Synthesis
MAINTENANCE AND OPERATION OF A SYNTHETIC CHEMICAL FACILITY $20, 04 R4
Chemistry, Analytical
EFFECT OF SPECIFIC COMPONENTS OF HUMAN MILK ON THE NURSLING *20, 10 R11
Chemistry, Clinical
ROLE OF ENHANCED CELL PROLIFERATION IN CHEMICAL CARCINOGENESIS $20, 07 R2
Chemistry, Organic
MAINTENANCE AND OPERATION OF A SYNTHETIC CHEMICAL FACILITY $20, 04 R4
Chemopreventive Agents
PREVENTION CLIN TRIALS USING INTERMED ENDPOINTS & MODULATION BY C *20, 07 R11
Chemotherapeutic Agents
COLLECTION AND TAXONOMY OF SHALLOW WATER MARINE ORGANISMS $20, 07 R4
DRUG DISCOVERY GROUPS TO TREAT COGNITIVE IMPAIRMENT WITH ALZHEIME *20, 09 R4
CLINICAL STUDIES TO TREAT COGNITIVE IMPAIRMENT IN ALZHEIMER'S DIS *20, 10 R6
Chemotherapy
HERPES SIMPLEX VIRUS IN PATHOGENESIS OF ORAL MUCOSITIS IN CANCER $20, 09 R2
A RANDOMIZED, PLACEBO-CONTROLLED TRIAL IN FIRST SEIZURE PATIENTS 20, 12 R1
Child Psychology/Development
PREVENTION OF LOW BIRTH WEIGHT 20, 02 P2
Children (Patients)
RESEARCH CENTER OF EXCELLENCE IN PEDIATRIC NEPHROLOGY AND UROLOGY *20, 04 R6
CHILD HEALTH RESEARCH CENTERS *20, 04 R7
EVALUATION OF VACCINE PROPHYLAXIS AGAINST INFECTIOUS DISEASES IN $20, 05 R1
DEVELOPMENT OF MODELS FOR PEDIATRIC AIDS *20, 05 R4
MECHANISMS OF HIV PATHOGENESIS IN PEDIATRIC POPULATIONS 20, 07 P1
Chimeric Models
TRANSGENIC, CHIMERIC, AND IN VITRO MODELS OF KIDNEY DISEASES 20, 12 P1
Chronic Fatigue
CHRONIC FATIGUE SYNDROME COOPERATIVE RESEARCH CENTERS *20, 06 R6
Claude D. Pepper Centers
CLAUDE D. PEPPER OLDER AMERICANS INDEPENDENCE CENTERS *20, 07 R12
Cleft Lip
EVALUATION OF TREATMENTS FOR CLEFT LIP AND/OR PALATE *20, 02 R3
Clinical Engineering
EVENT RECORDINGS OF HIGH RISK INFANTS ON APNEA MONITORS *20, 10 R3
Clinical Investigator Award
CLINICAL INVESTIGATOR AWARD FOR RESEARCH ON SPECIAL POPULATIONS *20, 10 R13
Clinical Medicine, General
CLINICAL CORE CENTERS FOR ORAL HEALTH RESEARCH *20, 01 R1
RESEARCH CENTERS IN ORAL BIOLOGY *20, 02 R4
PREVENTION OF LOW BIRTH WEIGHT 20, 02 P2
MANAGEMENT OF ALZHEIMER'S DISEASE SYMPTOMS *20, 03 R2
HEALTH IN OLDER AMERICANS AT HIGH RISK (NIDR RESEARCH & ACTION PR $20, 04 R1
CHILD HEALTH RESEARCH CENTERS *20, 04 R7
SPECIAL CARE UNITS FOR ALZHEIMER'S DISEASE *20, 04 R8
KIDNEY AND UROLOGY RESEARCH CENTERS *20, 05 R9
IMPROVED STRATEGIES FOR DIAGNOSIS OF LYME DISEASE *20, 06 R3
RURAL HEALTH CARE RESEARCH: IMPACTING VULNERABLE POPULATIONS 20, 06 P1
INCREASE IN TRAINING FUNDS FOR FY 1991 20, 11 N1
FACILITIES CONSTRUCTION PROJECTS: CENTERS FOR SUBSTANCE ABUSE RE *20, 12 R2
Clinical Mental Health
CLINICAL MENTAL HEALTH ACADEMIC AWARD 20, 13 P2
Clinical Psychology
CLINICAL MENTAL HEALTH ACADEMIC AWARD 20, 13 P2
Clinical Trial
EVALUATION OF TREATMENTS FOR CLEFT LIP AND/OR PALATE *20, 02 R3
SITES TESTING OSTEOPOROSIS PREVENTION/INTERVENTION TREATMENTS *20, 03 R4
STIMULATE CORRELATIVE LABORATORY STUDIES & CLINICAL TRIAL IN RADI *20, 06 R4
PREVENTION CLIN TRIALS USING INTERMED ENDPOINTS & MODULATION BY C *20, 07 R11
HERPES SIMPLEX VIRUS IN PATHOGENESIS OF ORAL MUCOSITIS IN CANCER $20, 09 R2
TRIALS OF BEHAVIORAL STRATEGIES TO PREVENT FURTHER SPREAD OF HIV *20, 10 R7
A RANDOMIZED, PLACEBO-CONTROLLED TRIAL IN FIRST SEIZURE PATIENTS 20, 12 R1
WOMEN'S HEALTH TRIAL: FEASIBILITY IN MINORITY POPULATIONS - CLIN $20, 13 R1
WOMEN'S HEALTH TRIAL: MINORITIES - STATISTICAL & NUTRITION COORD $20, 13 R2
Cognitive Development/Process
CLAUDE D. PEPPER OLDER AMERICANS INDEPENDENCE CENTERS *20, 07 R12
CLINICAL STUDIES TO TREAT COGNITIVE IMPAIRMENT IN ALZHEIMER'S DIS *20, 10 R6
Cognitive Impairment
DRUG DISCOVERY GROUPS TO TREAT COGNITIVE IMPAIRMENT WITH ALZHEIME *20, 09 R4
Community/Outreach Programs
PROMOTE APPLICATION OF STATE-OF-THE-ART CANCER MANAGEMENT IN RURA *20, 05 R8
RURAL HEALTH CARE RESEARCH: IMPACTING VULNERABLE POPULATIONS 20, 06 P1
EFFECTIVE DISSEMINATION OF HEALTH SERVICES RESEARCH FINDINGS & ME *20, 07 R9
RESEARCH AND DEMONSTRATION GRANTS RELATING TO OCCUPATIONAL SAFETY 20, 08 P1
RESEARCH & DEMONSTRATION GRANTS RELATING TO OCCUPATIONAL SAFETY & 20, 09 E3
Computer Modeling
DEVELOPMENT OF HIGH CONNECTIVITY NONMAMMALIAN MODELS 20, 08 P2
Computer Science
MEDICAL INFORMATICS RESEARCH TRAINING *20, 09 R5
Computer Storage & Retrieval
STUDY OF GRANT APPLICATION TEXTS IN ELECTRONIC FORM 20, 05 N2
EVENT RECORDINGS OF HIGH RISK INFANTS ON APNEA MONITORS *20, 10 R3
Computing Resources+
METHODS OF MOLECULAR MECHANICS AND DYNAMICS OF BIOPOLYMERS WORKSH 20, 04 N5
Conference
CONFERENCE: FOSTERING SCIENTIFIC INTEGRITY IN BIOMEDICAL RESEARC 20, 10 N1
Construction
CONSTRUCTION OF MOUSE PRODUCTION FACILITIES *20, 11 R3
Contraceptives
MAINTENANCE AND OPERATION OF A SYNTHETIC CHEMICAL FACILITY $20, 04 R4
COOPERATIVE CONTRACEPTIVE DEVELOPMENT RESEARCH CENTERS PROGRAM *20, 10 R10
Convulsive Disorders
A RANDOMIZED, PLACEBO-CONTROLLED TRIAL IN FIRST SEIZURE PATIENTS 20, 12 R1
Cooley's Anemia
GENE THERAPY STRATEGIES FOR TREATMENT OF COOLEY'S ANEMIA *20, 12 R3
Counsel, Drug Abuse
MAXIMIZE EFFICACY OF PSYCHOTHERAPY & DRUG ABUSE COUNSEL TO TREAT *20, 06 R5
Data Management/Analysis+
NATIONAL EPIDERMOLYSIS BULLOSA REGISTRY - CLINICAL COORDINATING C $20, 10 R1
NATIONAL EPIDERMOLYSIS BULLOSA REGISTRY - CLINICAL SITES $20, 10 R2
WOMEN'S HEALTH TRIAL: MINORITIES - STATISTICAL & NUTRITION COORD $20, 13 R2
INTERSTITIAL CYSTITIS DATA BASE: CLINICAL CENTERS & DATA COORDIN *20, 13 R6
Demography
INTERSTITIAL CYSTITIS DATA BASE: CLINICAL CENTERS & DATA COORDIN *20, 13 R6
Dental Health & Hygiene
SMALL GRANT PROGRAM 20, 12 P2
Dentistry
DETERMINANTS OF PERMANENT TOOTH LOSS IN THE U.S.A. $20, 11 R1
Depression
SHORT-TERM CLINICAL TRAINING GRANTS IN DIAGNOSIS & TREATMENT OF D *20, 10 R4
SHORT-TERM GRANTS TO TRAIN MEDICAL STUDENTS TO DIAGNOSE & TREAT D *20, 10 R5
Dermatology
NATIONAL EPIDERMOLYSIS BULLOSA REGISTRY - CLINICAL COORDINATING C $20, 10 R1
NATIONAL EPIDERMOLYSIS BULLOSA REGISTRY - CLINICAL SITES $20, 10 R2
Diabetes
RESEARCH PLANNING GRANT: DIABETES IN MINORITY POPULATIONS *20, 06 R7
THE UROLOGICAL COMPLICATIONS OF DIABETES MELLITUS 20, 06 P2
Diagnosis, Medical
IMPROVED STRATEGIES FOR DIAGNOSIS OF LYME DISEASE *20, 06 R3
RESEARCH PLANNING GRANT: DIABETES IN MINORITY POPULATIONS *20, 06 R7
SHORT-TERM CLINICAL TRAINING GRANTS IN DIAGNOSIS & TREATMENT OF D *20, 10 R4
SHORT-TERM GRANTS TO TRAIN MEDICAL STUDENTS TO DIAGNOSE & TREAT D *20, 10 R5
COOPERATIVE SPECIALIZED INFERTILITY RESEARCH CENTER PROGRAM *20, 10 R9
MINORITY ONCOLOGY LEADERSHIP ACADEMIC AWARD *20, 10 R12
PSYCHOPATHOLOGY AND MENTAL RETARDATION 20, 13 P1
Digestive System
CLINICAL TREATMENT AND CORRELATES OF UPPER GI CARCINOMA 20, 09 E1
DISCIPLINES/FIELDS, MEDICAL/BIOMED
SCIENCE EDUCATION PARTNERSHIP AWARD *20, 05 R10
Disease Control+
EVALUATION OF CONTROL MEASURES AGAINST INFECTIOUS DISEASES OTHER $20, 05 R2
MINORITY ONCOLOGY LEADERSHIP ACADEMIC AWARD *20, 10 R12
Disease Model
METHODS THAT REPLACE VERTEBRATES USED IN RESEARCH, OR THAT LESSEN 20, 02 P1
DEVELOPMENT OF MODELS FOR PEDIATRIC AIDS *20, 05 R4
ANIMAL MODELS FOR SUDDEN INFANT DEATH SYNDROME *20, 05 R7
ROLE OF ENHANCED CELL PROLIFERATION IN CHEMICAL CARCINOGENESIS $20, 07 R2
NON-HUMAN PRIMATE MODEL TO STUDY VACCINES IN PREGNANT FEMALES AND $20, 07 R3
DEVELOPMENT OF HIGH CONNECTIVITY NONMAMMALIAN MODELS 20, 08 P2
SUPERFUND HAZARDOUS SUBSTANCES BASIC RESEARCH PROGRAM *20, 11 R4
TRANSGENIC, CHIMERIC, AND IN VITRO MODELS OF KIDNEY DISEASES 20, 12 P1
CORRECTION: SUPERFUND HAZARDOUS SUBSTANCES BASIC RESEARCH PROGRA 20, 12 E1
Disease Prevention+
CLINICAL CORE CENTERS FOR ORAL HEALTH RESEARCH *20, 01 R1
ANALYSES AND PHYSIOLOGY OF ANTICARCINOGENS IN SOYBEANS *20, 03 R3
SITES TESTING OSTEOPOROSIS PREVENTION/INTERVENTION TREATMENTS *20, 03 R4
OSTEOPOROSIS PREVENTION/INTERVENTION TREATMENTS: PATHOPHYSIOL & *20, 03 R5
MATERNAL IMMUNIZATION TO PREVENT INFECTIOUS DISEASES IN NEONATES $20, 05 R3
KIDNEY AND UROLOGY RESEARCH CENTERS *20, 05 R9
RESEARCH PLANNING GRANT: DIABETES IN MINORITY POPULATIONS *20, 06 R7
MINORITY DRUG ABUSE PREVENTION RESEARCH CENTERS *20, 06 R8
CLINICAL AND EPIDEMIOLOGY RESEARCH ON OSTEOPOROSIS *20, 07 R8
CLAUDE D. PEPPER OLDER AMERICANS INDEPENDENCE CENTERS *20, 07 R12
MECHANISMS OF HIV PATHOGENESIS IN PEDIATRIC POPULATIONS 20, 07 P1
BIOMEDICAL ASPECTS OF OBESITY--PREVENTION AND TREATMENT 20, 08 N2
TRIALS OF BEHAVIORAL STRATEGIES TO PREVENT FURTHER SPREAD OF HIV *20, 10 R7
MINORITY ONCOLOGY LEADERSHIP ACADEMIC AWARD *20, 10 R12
SMALL GRANT PROGRAM 20, 12 P2
Dissertation Grants
MINORITY DISSERTATION RESEARCH GRANTS IN AGING, 1991 *20, 07 R10
Distribution of Research Resources
PHS POLICY ON DISTRIBUTION OF UNIQUE RES. RESOURCES PRODUCED WITH 20, 05 N7
Drug Design
PLACENTAL & PEDIATRIC METABOLISM, TOXICITY, & TRANSPORT OF anti-H *20, 05 R5
DRUG DISCOVERY GROUPS TO TREAT COGNITIVE IMPAIRMENT WITH ALZHEIME *20, 09 R4
Drug Discovery Groups
DRUG DISCOVERY GROUPS TO TREAT COGNITIVE IMPAIRMENT WITH ALZHEIME *20, 09 R4
Drugs/Drug Abuse
ADDENDUM: NIDA - ANNOUNCEMENT AND GUIDELINES - AUGUST 1990 20, 05 E1
MAXIMIZE EFFICACY OF PSYCHOTHERAPY & DRUG ABUSE COUNSEL TO TREAT *20, 06 R5
MINORITY DRUG ABUSE PREVENTION RESEARCH CENTERS *20, 06 R8
DRUG ABUSE TREATMENT EVALUATION RESEARCH CENTER GRANTS *20, 09 R3
INCREASE IN TRAINING FUNDS FOR FY 1991 20, 11 N1
VULNERABILITY TO DRUG ABUSE 20, 11 P1
FACILITIES CONSTRUCTION PROJECTS: CENTERS FOR SUBSTANCE ABUSE RE *20, 12 R2
Early Diagnosis of HIV
HIV IN MOTHERS AND INFANTS: IMMUNITY AND EARLY DIAGNOSIS *20, 05 R6
Ecology
SUPERFUND HAZARDOUS SUBSTANCES BASIC RESEARCH PROGRAM *20, 11 R4
CORRECTION: SUPERFUND HAZARDOUS SUBSTANCES BASIC RESEARCH PROGRA 20, 12 E1
EDUCATION/INSTRUCTION
SCIENCE EDUCATION PARTNERSHIP AWARD *20, 05 R10
Educational Instruction Programs
WORLD AIDS FOUNDATION 20, 07 N2
WORLD AIDS FOUNDATION 20, 09 N1
Emotional/Mental Health
PSYCHOPATHOLOGY AND MENTAL RETARDATION 20, 13 P1
CLINICAL MENTAL HEALTH ACADEMIC AWARD 20, 13 P2
Endocrinology
BASIC RESEARCH ON OSTEOPOROSIS *20, 07 R7
ENVIRONMENT
ACADEMIC AWARD IN ENVIRONMENTAL/OCCUPATIONAL MEDICINE 20, 09 P2
SHORT-TERM TRAINING FOR MEDICAL STUDENTS IN ENVIRONMENTAL/OCCUPAT 20, 09 P3
Environmental Effects
SUPERFUND HAZARDOUS SUBSTANCES BASIC RESEARCH PROGRAM *20, 11 R4
CORRECTION: SUPERFUND HAZARDOUS SUBSTANCES BASIC RESEARCH PROGRA 20, 12 E1
Epidemiology
HEALTH IN OLDER AMERICANS AT HIGH RISK (NIDR RESEARCH & ACTION PR $20, 04 R1
KIDNEY AND UROLOGY RESEARCH CENTERS *20, 05 R9
RURAL HEALTH CARE RESEARCH: IMPACTING VULNERABLE POPULATIONS 20, 06 P1
CLINICAL AND EPIDEMIOLOGY RESEARCH ON OSTEOPOROSIS *20, 07 R8
CLINICAL INVESTIGATOR AWARD FOR RESEARCH ON SPECIAL POPULATIONS *20, 10 R13
INCREASE IN TRAINING FUNDS FOR FY 1991 20, 11 N1
SMALL GRANT PROGRAM 20, 12 P2
Epidermolysis Bullosa Registry
NATIONAL EPIDERMOLYSIS BULLOSA REGISTRY - CLINICAL COORDINATING C $20, 10 R1
NATIONAL EPIDERMOLYSIS BULLOSA REGISTRY - CLINICAL SITES $20, 10 R2
Ethics/Values in Science & Technol
SCIENTIFIC MISCONDUCT: LIVING WITH THE NEW REGULATIONS: THE FIR 20, 02 N1
CONFERENCE, SCIENTIFIC INTEGRITY; MAJOR ISSUES FACED BY RESEARCH 20, 02 N3
CONFERENCE: FOSTERING SCIENTIFIC INTEGRITY IN BIOMEDICAL RESEARC 20, 02 N4
CONFERENCE: FOSTERING SCIENTIFIC INTEGRITY IN BIOMEDICAL RESEARC 20, 04 N3
CONFERENCE: FOSTERING SCIENTIFIC INTEGRITY IN BIOMEDICAL RESEARC 20, 06 N3
ANNUAL REPORT AND ASSURANCE ON POSSIBLE SCIENTIFIC MISCONDUCT 20, 09 N4
CONFERENCE: FOSTERING SCIENTIFIC INTEGRITY IN BIOMEDICAL RESEARC 20, 10 N1
Etiology
ALZHEIMER'S DISEASE AND RELATED CEREBRAL DEGENERATIVE DISORDERS *20, 03 R1
MULTICENTER COOPERATIVE AGREEMENT TO STUDY NEURAL TUBE DEFECTS IN *20, 05 R11
RESEARCH PLANNING GRANT: DIABETES IN MINORITY POPULATIONS *20, 06 R7
MINORITY DRUG ABUSE PREVENTION RESEARCH CENTERS *20, 06 R8
CLINICAL AND EPIDEMIOLOGY RESEARCH ON OSTEOPOROSIS *20, 07 R8
STUDIES ON ETIOLOGY & PATHOGENESIS OF POLYCYSTIC KIDNEY DISEASE *20, 10 R8
MINORITY ONCOLOGY LEADERSHIP ACADEMIC AWARD *20, 10 R12
VULNERABILITY TO DRUG ABUSE 20, 11 P1
SMALL GRANT PROGRAM 20, 12 P2
Facilities Construction Projects
FACILITIES CONSTRUCTION PROJECTS: CENTERS FOR SUBSTANCE ABUSE RE *20, 12 R2
Fellowship, Predoctoral
PREDOCTORAL FELLOWSHIP AWARDS FOR MINORITY STUDENTS *20, 07 R6
First Seizure Patients
A RANDOMIZED, PLACEBO-CONTROLLED TRIAL IN FIRST SEIZURE PATIENTS 20, 12 R1
Gene Therapy+
GENE THERAPY STRATEGIES FOR TREATMENT OF COOLEY'S ANEMIA *20, 12 R3
Genetics
RESEARCH CENTERS IN ORAL BIOLOGY *20, 02 R4
MULTICENTER COOPERATIVE AGREEMENT TO STUDY NEURAL TUBE DEFECTS IN *20, 05 R11
MOLECULAR ANALYSES OF RADIATION-INDUCED GENETIC DAMAGE *20, 07 R5
Grant Texts in Electronic Form
STUDY OF GRANT APPLICATION TEXTS IN ELECTRONIC FORM 20, 05 N2
Grants Administration/Policy+
NATIONAL RESEARCH SERVICE AWARD STIPEND INCREASE 20, 01 N1
SCIENTIFIC MISCONDUCT: LIVING WITH THE NEW REGULATIONS: THE FIR 20, 02 N1
CONFERENCE, SCIENTIFIC INTEGRITY; MAJOR ISSUES FACED BY RESEARCH 20, 02 N3
CONFERENCE: FOSTERING SCIENTIFIC INTEGRITY IN BIOMEDICAL RESEARC 20, 02 N4
SMALL GRANTS PROGRAM - REVISED GUIDELINES 20, 03 N2
"OTHER SUPPORT" IN PHS GRANT APPLICATIONS 20, 04 N1
"OTHER SUPPORT" IN NIH AND ADAMHA R&D CONTRACT PROPOSALS 20, 04 N2
CONFERENCE: FOSTERING SCIENTIFIC INTEGRITY IN BIOMEDICAL RESEARC 20, 04 N3
ACADEMIC RESEARCH ENHANCEMENT AWARD 20, 04 P1
TYPE SIZE IN PHS 398 APPLICATIONS 20, 05 N1
NIAMS PROGRAM PROJECT GUIDELINES 20, 05 N4
ANNOUNCEMENT OF HHS GRANTS AND CONTRACTS TRAINING COURSE 20, 05 N5
SALARY LIMITATION ON GRANTS AND CONTRACTS 20, 05 N6
ADDENDUM: NIDA - ANNOUNCEMENT AND GUIDELINES - AUGUST 1990 20, 05 E1
NIH/ADAMHA POLICY CONCERNING INCLUSION OF WOMEN IN STUDY POPULATI 20, 06 N1
ADAMHA/NIH POLICY CONCERNING INCLUSION OF MINORITIES IN STUDY POP 20, 06 N2
CONFERENCE: FOSTERING SCIENTIFIC INTEGRITY IN BIOMEDICAL RESEARC 20, 06 N3
INCREASED STIPENDS FOR APPOINTEES TO MINORITY ACCESS TO RESEARCH 20, 07 N1
ANNUAL REPORT AND ASSURANCE ON POSSIBLE SCIENTIFIC MISCONDUCT 20, 09 N4
CONSTRUCTION OF MOUSE PRODUCTION FACILITIES *20, 11 R3
REVIEW PROCEDURES FOR NEW COMPETITIVE PROGRAM PROJECT GRANT APPLI 20, 12 N1
NIH REGIONAL SEMINAR IN GRANTS ADMINISTRATION 20, 12 N2
Grants Training Course
ANNOUNCEMENT OF HHS GRANTS AND CONTRACTS TRAINING COURSE 20, 05 N5
Growth Factors
BASIC RESEARCH ON OSTEOPOROSIS *20, 07 R7
CLINICAL AND EPIDEMIOLOGY RESEARCH ON OSTEOPOROSIS *20, 07 R8
EFFECT OF SPECIFIC COMPONENTS OF HUMAN MILK ON THE NURSLING *20, 10 R11
DEVELOPMENTAL STUDIES HYBRIDOMA BANK $20, 11 R2
HEALTH CARE
RURAL HEALTH CARE RESEARCH: IMPACTING VULNERABLE POPULATIONS 20, 06 P1
EFFECTIVE DISSEMINATION OF HEALTH SERVICES RESEARCH FINDINGS & ME *20, 07 R9
Health Promotion
EXPLORATORY CENTERS FOR HEALTH BEHAVIOR RESEARCH WITH CHILDREN & *20, 09 R6
Health Services Delivery
RURAL HEALTH CARE RESEARCH: IMPACTING VULNERABLE POPULATIONS 20, 06 P1
EFFECTIVE DISSEMINATION OF HEALTH SERVICES RESEARCH FINDINGS & ME *20, 07 R9
Health, Radiation Effects
MOLECULAR ANALYSES OF RADIATION-INDUCED GENETIC DAMAGE *20, 07 R5
Hematology
POSTDOCTORAL FELLOWSHIPS AND SENIOR FELLOWSHIPS IN HEMATOLOGIC RE 20, 11 P2
Herpes Simplex Virus
HERPES SIMPLEX VIRUS IN PATHOGENESIS OF ORAL MUCOSITIS IN CANCER $20, 09 R2
HIV Infection
TRIALS OF BEHAVIORAL STRATEGIES TO PREVENT FURTHER SPREAD OF HIV *20, 10 R7
Hormones
BASIC RESEARCH ON OSTEOPOROSIS *20, 07 R7
CLINICAL AND EPIDEMIOLOGY RESEARCH ON OSTEOPOROSIS *20, 07 R8
EFFECT OF SPECIFIC COMPONENTS OF HUMAN MILK ON THE NURSLING *20, 10 R11
Human Genome
MINORITY INSTITUTIONS TRAVEL AWARD PROGRAM 20, 01 P1
HUMAN GENOME PROGRAM DEVELOPMENTAL GRANTS *20, 13 R4
Human Milk
EFFECT OF SPECIFIC COMPONENTS OF HUMAN MILK ON THE NURSLING *20, 10 R11
Human Reproduction/Fertility
COOPERATIVE SPECIALIZED INFERTILITY RESEARCH CENTER PROGRAM *20, 10 R9
COOPERATIVE CONTRACEPTIVE DEVELOPMENT RESEARCH CENTERS PROGRAM *20, 10 R10
Human Subjects Policy
NATIONAL WORKSHOPS ON "PROTECTION OF HUMAN SUBJECTS" 20, 01 N2
NATIONAL WORKSHOPS ON "PROTECTION OF HUMAN SUBJECTS" 20, 02 N2
NATIONAL WORKSHOPS ON "PROTECTION OF HUMAN SUBJECTS" 20, 03 N1
NATIONAL WORKSHOPS ON "PROTECTION OF HUMAN SUBJECTS" 20, 05 N3
NATIONAL WORKSHOPS ON "PROTECTION OF HUMAN SUBJECTS" 20, 06 N4
NATIONAL WORKSHOPS ON "PROTECTION OF HUMAN SUBJECTS" 20, 08 N1
NATIONAL WORKSHOPS ON "PROTECTION OF HUMAN SUBJECTS" 20, 09 N3
NATIONAL WORKSHOPS ON "PROTECTION OF HUMAN SUBJECTS" 20, 13 N1
Hybridoma Bank
DEVELOPMENTAL STUDIES HYBRIDOMA BANK $20, 11 R2
Hybridomas
DEVELOPMENTAL STUDIES HYBRIDOMA BANK $20, 11 R2
Immune Enhancers
MUCOSAL IMMUNIZATION RESEARCH GROUP $20, 07 R1
Immunology
RESEARCH CENTERS IN ORAL BIOLOGY *20, 02 R4
HIV IN MOTHERS AND INFANTS: IMMUNITY AND EARLY DIAGNOSIS *20, 05 R6
IMPROVED STRATEGIES FOR DIAGNOSIS OF LYME DISEASE *20, 06 R3
CHRONIC FATIGUE SYNDROME COOPERATIVE RESEARCH CENTERS *20, 06 R6
MUCOSAL IMMUNIZATION RESEARCH GROUP $20, 07 R1
MECHANISMS OF HIV PATHOGENESIS IN PEDIATRIC POPULATIONS 20, 07 P1
RESEARCH UNITS ON PELVIC INFLAMMATORY DISEASE AND ITS SEQUELAE *20, 10 R15
DEVELOPMENTAL STUDIES HYBRIDOMA BANK $20, 11 R2
In Vitro Models
TRANSGENIC, CHIMERIC, AND IN VITRO MODELS OF KIDNEY DISEASES 20, 12 P1
Infants
PREVENTION OF LOW BIRTH WEIGHT 20, 02 P2
MATERNAL IMMUNIZATION TO PREVENT INFECTIOUS DISEASES IN NEONATES $20, 05 R3
HIV IN MOTHERS AND INFANTS: IMMUNITY AND EARLY DIAGNOSIS *20, 05 R6
EVENT RECORDINGS OF HIGH RISK INFANTS ON APNEA MONITORS *20, 10 R3
Infectious Diseases/Agents
MONONUCLEAR PHAGOCYTES IN OPPORTUNISTIC INFECTIONS OF ORAL MUCOSA $20, 02 R2
EVALUATION OF VACCINE PROPHYLAXIS AGAINST INFECTIOUS DISEASES IN $20, 05 R1
EVALUATION OF CONTROL MEASURES AGAINST INFECTIOUS DISEASES OTHER $20, 05 R2
MATERNAL IMMUNIZATION TO PREVENT INFECTIOUS DISEASES IN NEONATES $20, 05 R3
IMPROVED STRATEGIES FOR DIAGNOSIS OF LYME DISEASE *20, 06 R3
CHRONIC FATIGUE SYNDROME COOPERATIVE RESEARCH CENTERS *20, 06 R6
THE UROLOGICAL COMPLICATIONS OF DIABETES MELLITUS 20, 06 P2
NON-HUMAN PRIMATE MODEL TO STUDY VACCINES IN PREGNANT FEMALES AND $20, 07 R3
MECHANISMS OF HIV PATHOGENESIS IN PEDIATRIC POPULATIONS 20, 07 P1
Infertility Research Center
COOPERATIVE SPECIALIZED INFERTILITY RESEARCH CENTER PROGRAM *20, 10 R9
Inflammation
CHRONIC FATIGUE SYNDROME COOPERATIVE RESEARCH CENTERS *20, 06 R6
RESEARCH UNITS ON PELVIC INFLAMMATORY DISEASE AND ITS SEQUELAE *20, 10 R15
Information Science/Systems
MEDICAL INFORMATICS RESEARCH TRAINING *20, 09 R5
Injury
RESEARCH AND DEMONSTRATION GRANTS RELATING TO OCCUPATIONAL SAFETY 20, 08 P1
RESEARCH & DEMONSTRATION GRANTS RELATING TO OCCUPATIONAL SAFETY & 20, 09 E3
Instrumentation, Medical
BIOMEDICAL RESEARCH SUPPORT SHARED INSTRUMENTATION GRANTS 20, 01 P3
Instrumentation, Scientific
BIOMEDICAL RESEARCH SUPPORT SHARED INSTRUMENTATION GRANTS 20, 01 P3
INSTRUMENTS/INSTRUMENTATION/DEVICE
BIOMEDICAL RESEARCH SUPPORT SHARED INSTRUMENTATION GRANTS 20, 01 P3
Intermediate Endpoints
PREVENTION CLIN TRIALS USING INTERMED ENDPOINTS & MODULATION BY C *20, 07 R11
Interstitial Cystitis
INTERSTITIAL CYSTITIS DATA BASE: CLINICAL CENTERS & DATA COORDIN *20, 13 R6
Kaposi's Sarcoma
KAPOSI'S SARCOMA: CELL CYCLE STUDIES OF VASCULAR CELLS *20, 13 R5
Liver Cell Culture
HUMAN LIVER CELL CULTURE FACILITY $20, 06 R2
Low Birth Weight
PREVENTION OF LOW BIRTH WEIGHT 20, 02 P2
Lyme Disease
IMPROVED STRATEGIES FOR DIAGNOSIS OF LYME DISEASE *20, 06 R3
Magnetic Resonance Imaging
CEREBRAL MAGNETIC RESONANCE IMAGING TO EVALUATE STROKE RISK FACTO $20, 06 R1
Maternal Immunization
MATERNAL IMMUNIZATION TO PREVENT INFECTIOUS DISEASES IN NEONATES $20, 05 R3
Mechanisms of HIV Pathogenesis
MECHANISMS OF HIV PATHOGENESIS IN PEDIATRIC POPULATIONS 20, 07 P1
Medical Informatics
MEDICAL INFORMATICS RESEARCH TRAINING *20, 09 R5
Medical Practice
EFFECTIVE DISSEMINATION OF HEALTH SERVICES RESEARCH FINDINGS & ME *20, 07 R9
Medical Rehabilitation Research
NRSA INSTITUTIONAL TRAINING GRANTS IN MEDICAL REHABILITATION RESE *20, 13 R3
Medical/Diagnostic Imaging
CEREBRAL MAGNETIC RESONANCE IMAGING TO EVALUATE STROKE RISK FACTO $20, 06 R1
Membrane Structure/Function
POSTDOCTORAL FELLOWSHIPS AND SENIOR FELLOWSHIPS IN HEMATOLOGIC RE 20, 11 P2
Mental Disorders
CLINICAL MENTAL HEALTH ACADEMIC AWARD 20, 13 P2
Mental Retardation
PSYCHOPATHOLOGY AND MENTAL RETARDATION 20, 13 P1
Metabolism
BIOMEDICAL ASPECTS OF OBESITY--PREVENTION AND TREATMENT 20, 08 N2
Metabolism, Mineral
BASIC RESEARCH ON OSTEOPOROSIS *20, 07 R7
POSTDOCTORAL FELLOWSHIPS AND SENIOR FELLOWSHIPS IN HEMATOLOGIC RE 20, 11 P2
Microbiology
RESEARCH CENTERS IN ORAL BIOLOGY *20, 02 R4
RESEARCH UNITS ON PELVIC INFLAMMATORY DISEASE AND ITS SEQUELAE *20, 10 R15
Microstimulator
INDUCTIVELY POWERED MICROSTIMULATOR $20, 08 R1
Minorities
ADAMHA/NIH POLICY CONCERNING INCLUSION OF MINORITIES IN STUDY POP 20, 06 N2
RESEARCH PLANNING GRANT: DIABETES IN MINORITY POPULATIONS *20, 06 R7
MINORITY DRUG ABUSE PREVENTION RESEARCH CENTERS *20, 06 R8
INCREASED STIPENDS FOR APPOINTEES TO MINORITY ACCESS TO RESEARCH 20, 07 N1
PREDOCTORAL FELLOWSHIP AWARDS FOR MINORITY STUDENTS *20, 07 R6
MINORITY DISSERTATION RESEARCH GRANTS IN AGING, 1991 *20, 07 R10
PREDOCTORAL FELLOWSHIP AWARDS FOR MINORITY STUDENTS 20, 09 E2
MINORITY ONCOLOGY LEADERSHIP ACADEMIC AWARD *20, 10 R12
MINORITY SCHOOL FACULTY DEVELOPMENT AWARD *20, 10 R14
WOMEN'S HEALTH TRIAL: FEASIBILITY IN MINORITY POPULATIONS - CLIN $20, 13 R1
WOMEN'S HEALTH TRIAL: MINORITIES - STATISTICAL & NUTRITION COORD $20, 13 R2
Minority Institutions
MINORITY INSTITUTIONS TRAVEL AWARD PROGRAM 20, 01 P1
Models for Pediatric AIDS
DEVELOPMENT OF MODELS FOR PEDIATRIC AIDS *20, 05 R4
Modulation by Chemoprevention
PREVENTION CLIN TRIALS USING INTERMED ENDPOINTS & MODULATION BY C *20, 07 R11
Molecular Analysis
MOLECULAR ANALYSES OF RADIATION-INDUCED GENETIC DAMAGE *20, 07 R5
Molecular Genetics
POSTDOCTORAL FELLOWSHIPS AND SENIOR FELLOWSHIPS IN HEMATOLOGIC RE 20, 11 P2
Monoclonal Antibodies
DEVELOPMENTAL STUDIES HYBRIDOMA BANK $20, 11 R2
Mononuclear Phagocytes
MONONUCLEAR PHAGOCYTES IN OPPORTUNISTIC INFECTIONS OF ORAL MUCOSA $20, 02 R2
Morphogenesis
MULTICENTER COOPERATIVE AGREEMENT TO STUDY NEURAL TUBE DEFECTS IN *20, 05 R11
Mouse Production Facilities
CONSTRUCTION OF MOUSE PRODUCTION FACILITIES *20, 11 R3
Mucosal Immunization
MUCOSAL IMMUNIZATION RESEARCH GROUP $20, 07 R1
Musculoskeletal System
SITES TESTING OSTEOPOROSIS PREVENTION/INTERVENTION TREATMENTS *20, 03 R4
OSTEOPOROSIS PREVENTION/INTERVENTION TREATMENTS: PATHOPHYSIOL & *20, 03 R5
NIAMS PROGRAM PROJECT GUIDELINES 20, 05 N4
BASIC RESEARCH ON OSTEOPOROSIS *20, 07 R7
CLINICAL AND EPIDEMIOLOGY RESEARCH ON OSTEOPOROSIS *20, 07 R8
Mutagenics
SALMONELLA MUTAGENICITY TESTING (SMALL BUSINESS SET ASIDE) $20, 04 R2
SALMONELLA MUTAGENICITY TESTING $20, 04 R3
MOLECULAR ANALYSES OF RADIATION-INDUCED GENETIC DAMAGE *20, 07 R5
Mutant Mice
MULTICENTER COOPERATIVE AGREEMENT TO STUDY NEURAL TUBE DEFECTS IN *20, 05 R11
NCI Outstanding Investigator
THE NCI OUTSTANDING INVESTIGATOR GRANT 20, 09 P1
Nephrology
RESEARCH CENTER OF EXCELLENCE IN PEDIATRIC NEPHROLOGY AND UROLOGY *20, 04 R6
KIDNEY AND UROLOGY RESEARCH CENTERS *20, 05 R9
STUDIES ON ETIOLOGY & PATHOGENESIS OF POLYCYSTIC KIDNEY DISEASE *20, 10 R8
TRANSGENIC, CHIMERIC, AND IN VITRO MODELS OF KIDNEY DISEASES 20, 12 P1
Neural Stimulation
INDUCTIVELY POWERED MICROSTIMULATOR $20, 08 R1
Neural Tube Defects
MULTICENTER COOPERATIVE AGREEMENT TO STUDY NEURAL TUBE DEFECTS IN *20, 05 R11
Neuroscience
ALZHEIMER'S DISEASE AND RELATED CEREBRAL DEGENERATIVE DISORDERS *20, 03 R1
New World Monkeys
NEW WORLD MONKEYS AVAILABLE FOR BIOMEDICAL RESEARCH 20, 09 N2
NIH Regional Seminar
NIH REGIONAL SEMINAR IN GRANTS ADMINISTRATION 20, 12 N2
Nonmammalian Models
DEVELOPMENT OF HIGH CONNECTIVITY NONMAMMALIAN MODELS 20, 08 P2
NRSA Institutional Grants
NRSA INSTITUTIONAL TRAINING GRANTS IN MEDICAL REHABILITATION RESE *20, 13 R3
NRSA Stipend Increase
NATIONAL RESEARCH SERVICE AWARD STIPEND INCREASE 20, 01 N1
Nucleic Acid Sequencing
HUMAN GENOME PROGRAM DEVELOPMENTAL GRANTS *20, 13 R4
Nucleic Acid Structure/Function
HUMAN GENOME PROGRAM DEVELOPMENTAL GRANTS *20, 13 R4
Nutrition/Dietetics
RESEARCH CENTERS IN ORAL BIOLOGY *20, 02 R4
ANALYSES AND PHYSIOLOGY OF ANTICARCINOGENS IN SOYBEANS *20, 03 R3
PREVENTION CLIN TRIALS USING INTERMED ENDPOINTS & MODULATION BY C *20, 07 R11
BIOMEDICAL ASPECTS OF OBESITY--PREVENTION AND TREATMENT 20, 08 N2
WOMEN'S HEALTH TRIAL: FEASIBILITY IN MINORITY POPULATIONS - CLIN $20, 13 R1
WOMEN'S HEALTH TRIAL: MINORITIES - STATISTICAL & NUTRITION COORD $20, 13 R2
Obesity
BIOMEDICAL ASPECTS OF OBESITY--PREVENTION AND TREATMENT 20, 08 N2
Occupational Health and Safety
RESEARCH AND DEMONSTRATION GRANTS RELATING TO OCCUPATIONAL SAFETY 20, 08 P1
ACADEMIC AWARD IN ENVIRONMENTAL/OCCUPATIONAL MEDICINE 20, 09 P2
SHORT-TERM TRAINING FOR MEDICAL STUDENTS IN ENVIRONMENTAL/OCCUPAT 20, 09 P3
RESEARCH & DEMONSTRATION GRANTS RELATING TO OCCUPATIONAL SAFETY & 20, 09 E3
Older Americans Health
HEALTH IN OLDER AMERICANS AT HIGH RISK (NIDR RESEARCH & ACTION PR $20, 04 R1
Oncology
MINORITY ONCOLOGY LEADERSHIP ACADEMIC AWARD *20, 10 R12
CLINICAL INVESTIGATOR AWARD FOR RESEARCH ON SPECIAL POPULATIONS *20, 10 R13
Oral Diseases
CLINICAL CORE CENTERS FOR ORAL HEALTH RESEARCH *20, 01 R1
EVALUATION OF TREATMENTS FOR CLEFT LIP AND/OR PALATE *20, 02 R3
RESEARCH CENTERS IN ORAL BIOLOGY *20, 02 R4
HEALTH IN OLDER AMERICANS AT HIGH RISK (NIDR RESEARCH & ACTION PR $20, 04 R1
DETERMINANTS OF PERMANENT TOOTH LOSS IN THE U.S.A. $20, 11 R1
SMALL GRANT PROGRAM 20, 12 P2
Oral Mucositis
HERPES SIMPLEX VIRUS IN PATHOGENESIS OF ORAL MUCOSITIS IN CANCER $20, 09 R2
Osteoporosis
SITES TESTING OSTEOPOROSIS PREVENTION/INTERVENTION TREATMENTS *20, 03 R4
OSTEOPOROSIS PREVENTION/INTERVENTION TREATMENTS: PATHOPHYSIOL & *20, 03 R5
BASIC RESEARCH ON OSTEOPOROSIS *20, 07 R7
CLINICAL AND EPIDEMIOLOGY RESEARCH ON OSTEOPOROSIS *20, 07 R8
Other Support
"OTHER SUPPORT" IN PHS GRANT APPLICATIONS 20, 04 N1
"OTHER SUPPORT" IN NIH AND ADAMHA R&D CONTRACT PROPOSALS 20, 04 N2
Pain
CHRONIC FATIGUE SYNDROME COOPERATIVE RESEARCH CENTERS *20, 06 R6
Pathogenesis
ALZHEIMER'S DISEASE AND RELATED CEREBRAL DEGENERATIVE DISORDERS *20, 03 R1
RESEARCH PLANNING GRANT: DIABETES IN MINORITY POPULATIONS *20, 06 R7
MECHANISMS OF HIV PATHOGENESIS IN PEDIATRIC POPULATIONS 20, 07 P1
HERPES SIMPLEX VIRUS IN PATHOGENESIS OF ORAL MUCOSITIS IN CANCER $20, 09 R2
STUDIES ON ETIOLOGY & PATHOGENESIS OF POLYCYSTIC KIDNEY DISEASE *20, 10 R8
Pathophysiology
OSTEOPOROSIS PREVENTION/INTERVENTION TREATMENTS: PATHOPHYSIOL & *20, 03 R5
BASIC & CLINICAL RESEARCH ON URINARY BLADDER & PELVIC MUSCULATURE *20, 04 R5
EVENT RECORDINGS OF HIGH RISK INFANTS ON APNEA MONITORS *20, 10 R3
POSTDOCTORAL FELLOWSHIPS AND SENIOR FELLOWSHIPS IN HEMATOLOGIC RE 20, 11 P2
Pediatrics
CHILD HEALTH RESEARCH CENTERS *20, 04 R7
PLACENTAL & PEDIATRIC METABOLISM, TOXICITY, & TRANSPORT OF anti-H *20, 05 R5
Pelvic Inflammatory Disease
RESEARCH UNITS ON PELVIC INFLAMMATORY DISEASE AND ITS SEQUELAE *20, 10 R15
Pelvic Musculature
BASIC & CLINICAL RESEARCH ON URINARY BLADDER & PELVIC MUSCULATURE *20, 04 R5
Peptides
METHODS OF MOLECULAR MECHANICS AND DYNAMICS OF BIOPOLYMERS WORKSH 20, 04 N5
Permanent Tooth Loss
DETERMINANTS OF PERMANENT TOOTH LOSS IN THE U.S.A. $20, 11 R1
Pharmacology
COOPERATIVE CONTRACEPTIVE DEVELOPMENT RESEARCH CENTERS PROGRAM *20, 10 R10
PHS Policy on Resources
PHS POLICY ON DISTRIBUTION OF UNIQUE RES. RESOURCES PRODUCED WITH 20, 05 N7
Physical Growth/Retardation
PREVENTION OF LOW BIRTH WEIGHT 20, 02 P2
EFFECT OF SPECIFIC COMPONENTS OF HUMAN MILK ON THE NURSLING *20, 10 R11
Physical Medicine and Rehab.
NRSA INSTITUTIONAL TRAINING GRANTS IN MEDICAL REHABILITATION RESE *20, 13 R3
Physiological Controls and System
ARTIFICIAL LUNG RESEARCH AND DEVELOPMENT $20, 02 R1
PHYSIOLOGICAL/DEVELOPMENT PROCESS
CHILD HEALTH RESEARCH CENTERS *20, 04 R7
DEVELOPMENTAL STUDIES HYBRIDOMA BANK $20, 11 R2
Placental Metabolism
PLACENTAL & PEDIATRIC METABOLISM, TOXICITY, & TRANSPORT OF anti-H *20, 05 R5
Polycystic Kidney Disease
STUDIES ON ETIOLOGY & PATHOGENESIS OF POLYCYSTIC KIDNEY DISEASE *20, 10 R8
Pregnancy
MATERNAL IMMUNIZATION TO PREVENT INFECTIOUS DISEASES IN NEONATES $20, 05 R3
HIV IN MOTHERS AND INFANTS: IMMUNITY AND EARLY DIAGNOSIS *20, 05 R6
NON-HUMAN PRIMATE MODEL TO STUDY VACCINES IN PREGNANT FEMALES AND $20, 07 R3
Preservation of Organs/Tissue
HUMAN LIVER CELL CULTURE FACILITY $20, 06 R2
Primate Model for Vaccines
NON-HUMAN PRIMATE MODEL TO STUDY VACCINES IN PREGNANT FEMALES AND $20, 07 R3
Program Project Applications
REVIEW PROCEDURES FOR NEW COMPETITIVE PROGRAM PROJECT GRANT APPLI 20, 12 N1
Program Project Guidelines
NIAMS PROGRAM PROJECT GUIDELINES 20, 05 N4
Prosthetic Device, Neural
INDUCTIVELY POWERED MICROSTIMULATOR $20, 08 R1
Prosthetic Devices (General)
ARTIFICIAL LUNG RESEARCH AND DEVELOPMENT $20, 02 R1
Psychopathology
PSYCHOPATHOLOGY AND MENTAL RETARDATION 20, 13 P1
Psychotherapy
MAXIMIZE EFFICACY OF PSYCHOTHERAPY & DRUG ABUSE COUNSEL TO TREAT *20, 06 R5
SHORT-TERM CLINICAL TRAINING GRANTS IN DIAGNOSIS & TREATMENT OF D *20, 10 R4
SHORT-TERM GRANTS TO TRAIN MEDICAL STUDENTS TO DIAGNOSE & TREAT D *20, 10 R5
Radiation-Induced Genetic Damage
MOLECULAR ANALYSES OF RADIATION-INDUCED GENETIC DAMAGE *20, 07 R5
Radiotherapy
STIMULATE CORRELATIVE LABORATORY STUDIES & CLINICAL TRIAL IN RADI *20, 06 R4
Receptors
BASIC RESEARCH ON OSTEOPOROSIS *20, 07 R7
Registries+
NATIONAL EPIDERMOLYSIS BULLOSA REGISTRY - CLINICAL COORDINATING C $20, 10 R1
NATIONAL EPIDERMOLYSIS BULLOSA REGISTRY - CLINICAL SITES $20, 10 R2
Rehabilitation/Therapy, Emotional
PSYCHOPATHOLOGY AND MENTAL RETARDATION 20, 13 P1
Research Findings
EFFECTIVE DISSEMINATION OF HEALTH SERVICES RESEARCH FINDINGS & ME *20, 07 R9
RESEARCH RESOURCES
SALMONELLA MUTAGENICITY TESTING (SMALL BUSINESS SET ASIDE) $20, 04 R2
SALMONELLA MUTAGENICITY TESTING $20, 04 R3
NEW WORLD MONKEYS AVAILABLE FOR BIOMEDICAL RESEARCH 20, 09 N2
DEVELOPMENTAL STUDIES HYBRIDOMA BANK $20, 11 R2
Research Training
BIOTECHNOLOGY RESEARCH TRAINING 20, 01 P2
Respiratory System
ARTIFICIAL LUNG RESEARCH AND DEVELOPMENT $20, 02 R1
Risk Factors/Analysis
HEALTH IN OLDER AMERICANS AT HIGH RISK (NIDR RESEARCH & ACTION PR $20, 04 R1
CEREBRAL MAGNETIC RESONANCE IMAGING TO EVALUATE STROKE RISK FACTO $20, 06 R1
MINORITY DRUG ABUSE PREVENTION RESEARCH CENTERS *20, 06 R8
CLINICAL INVESTIGATOR AWARD FOR RESEARCH ON SPECIAL POPULATIONS *20, 10 R13
DETERMINANTS OF PERMANENT TOOTH LOSS IN THE U.S.A. $20, 11 R1
VULNERABILITY TO DRUG ABUSE 20, 11 P1
Rural Health Care Research
RURAL HEALTH CARE RESEARCH: IMPACTING VULNERABLE POPULATIONS 20, 06 P1
Salmonella Testing
SALMONELLA MUTAGENICITY TESTING (SMALL BUSINESS SET ASIDE) $20, 04 R2
SALMONELLA MUTAGENICITY TESTING $20, 04 R3
Schizophrenia
CLINICAL MENTAL HEALTH ACADEMIC AWARD 20, 13 P2
Science Education Partnership
SCIENCE EDUCATION PARTNERSHIP AWARD *20, 05 R10
SCIENCE PLANNING/POLICY
"OTHER SUPPORT" IN PHS GRANT APPLICATIONS 20, 04 N1
"OTHER SUPPORT" IN NIH AND ADAMHA R&D CONTRACT PROPOSALS 20, 04 N2
STUDY OF GRANT APPLICATION TEXTS IN ELECTRONIC FORM 20, 05 N2
ANNOUNCEMENT OF HHS GRANTS AND CONTRACTS TRAINING COURSE 20, 05 N5
NIH/ADAMHA POLICY CONCERNING INCLUSION OF WOMEN IN STUDY POPULATI 20, 06 N1
ADAMHA/NIH POLICY CONCERNING INCLUSION OF MINORITIES IN STUDY POP 20, 06 N2
PREDOCTORAL FELLOWSHIP AWARDS FOR MINORITY STUDENTS *20, 07 R6
PREDOCTORAL FELLOWSHIP AWARDS FOR MINORITY STUDENTS 20, 09 E2
CONSTRUCTION OF MOUSE PRODUCTION FACILITIES *20, 11 R3
REVIEW PROCEDURES FOR NEW COMPETITIVE PROGRAM PROJECT GRANT APPLI 20, 12 N1
Scientific Integrity
CONFERENCE, SCIENTIFIC INTEGRITY; MAJOR ISSUES FACED BY RESEARCH 20, 02 N3
CONFERENCE: FOSTERING SCIENTIFIC INTEGRITY IN BIOMEDICAL RESEARC 20, 02 N4
CONFERENCE: FOSTERING SCIENTIFIC INTEGRITY IN BIOMEDICAL RESEARC 20, 04 N3
CONFERENCE: FOSTERING SCIENTIFIC INTEGRITY IN BIOMEDICAL RESEARC 20, 06 N3
Scientific Misconduct
SCIENTIFIC MISCONDUCT: LIVING WITH THE NEW REGULATIONS: THE FIR 20, 02 N1
ANNUAL REPORT AND ASSURANCE ON POSSIBLE SCIENTIFIC MISCONDUCT 20, 09 N4
Senile Dementia
ALZHEIMER'S DISEASE AND RELATED CEREBRAL DEGENERATIVE DISORDERS *20, 03 R1
MANAGEMENT OF ALZHEIMER'S DISEASE SYMPTOMS *20, 03 R2
SPECIAL CARE UNITS FOR ALZHEIMER'S DISEASE *20, 04 R8
DRUG DISCOVERY GROUPS TO TREAT COGNITIVE IMPAIRMENT WITH ALZHEIME *20, 09 R4
CLINICAL STUDIES TO TREAT COGNITIVE IMPAIRMENT IN ALZHEIMER'S DIS *20, 10 R6
Shared Instrumentation Grants
BIOMEDICAL RESEARCH SUPPORT SHARED INSTRUMENTATION GRANTS 20, 01 P3
Short-Term Clinical Training
SHORT-TERM CLINICAL TRAINING GRANTS IN DIAGNOSIS & TREATMENT OF D *20, 10 R4
Short-Term Grants
SHORT-TERM GRANTS TO TRAIN MEDICAL STUDENTS TO DIAGNOSE & TREAT D *20, 10 R5
Short-Term Training
SHORT-TERM TRAINING FOR MEDICAL STUDENTS IN ENVIRONMENTAL/OCCUPAT 20, 09 P3
Skin Diseases
NIAMS PROGRAM PROJECT GUIDELINES 20, 05 N4
Small Grant Program
SMALL GRANT PROGRAM 20, 12 P2
Small Grants
SMALL GRANTS PROGRAM - REVISED GUIDELINES 20, 03 N2
Steroids
MAINTENANCE AND OPERATION OF A SYNTHETIC CHEMICAL FACILITY $20, 04 R4
Stipend Increase
INCREASED STIPENDS FOR APPOINTEES TO MINORITY ACCESS TO RESEARCH 20, 07 N1
Stroke
CEREBRAL MAGNETIC RESONANCE IMAGING TO EVALUATE STROKE RISK FACTO $20, 06 R1
Sudden Infant Death Syndrome
ANIMAL MODELS FOR SUDDEN INFANT DEATH SYNDROME *20, 05 R7
Superfund Hazardous Substances
SUPERFUND HAZARDOUS SUBSTANCES BASIC RESEARCH PROGRAM *20, 11 R4
CORRECTION: SUPERFUND HAZARDOUS SUBSTANCES BASIC RESEARCH PROGRA 20, 12 E1
Surgery
EVALUATION OF TREATMENTS FOR CLEFT LIP AND/OR PALATE *20, 02 R3
ANIMAL WELFARE EDUCATION PROGRAM: SURGERY AND POST-SURGICAL CARE 20, 04 N4
CLINICAL INVESTIGATOR AWARD FOR RESEARCH ON SPECIAL POPULATIONS *20, 10 R13
Synthetic Chemical Facility
MAINTENANCE AND OPERATION OF A SYNTHETIC CHEMICAL FACILITY $20, 04 R4
Taxonomy of Marine Organisms
COLLECTION AND TAXONOMY OF SHALLOW WATER MARINE ORGANISMS $20, 07 R4
Therapy Evaluation
EVALUATION OF TREATMENTS FOR CLEFT LIP AND/OR PALATE *20, 02 R3
DRUG ABUSE TREATMENT EVALUATION RESEARCH CENTER GRANTS *20, 09 R3
CLINICAL STUDIES TO TREAT COGNITIVE IMPAIRMENT IN ALZHEIMER'S DIS *20, 10 R6
Tissue Culture
METHODS THAT REPLACE VERTEBRATES USED IN RESEARCH, OR THAT LESSEN 20, 02 P1
Toxicology
ANALYSES AND PHYSIOLOGY OF ANTICARCINOGENS IN SOYBEANS *20, 03 R3
PLACENTAL & PEDIATRIC METABOLISM, TOXICITY, & TRANSPORT OF anti-H *20, 05 R5
SUPERFUND HAZARDOUS SUBSTANCES BASIC RESEARCH PROGRAM *20, 11 R4
CORRECTION: SUPERFUND HAZARDOUS SUBSTANCES BASIC RESEARCH PROGRA 20, 12 E1
Training Funds for FY 1991
INCREASE IN TRAINING FUNDS FOR FY 1991 20, 11 N1
Transgenic Models
TRANSGENIC, CHIMERIC, AND IN VITRO MODELS OF KIDNEY DISEASES 20, 12 P1
Travel Award Program
MINORITY INSTITUTIONS TRAVEL AWARD PROGRAM 20, 01 P1
Treatment, Medical+
KIDNEY AND UROLOGY RESEARCH CENTERS *20, 05 R9
RESEARCH PLANNING GRANT: DIABETES IN MINORITY POPULATIONS *20, 06 R7
BIOMEDICAL ASPECTS OF OBESITY--PREVENTION AND TREATMENT 20, 08 N2
CLINICAL TREATMENT AND CORRELATES OF UPPER GI CARCINOMA 20, 09 E1
SHORT-TERM CLINICAL TRAINING GRANTS IN DIAGNOSIS & TREATMENT OF D *20, 10 R4
SHORT-TERM GRANTS TO TRAIN MEDICAL STUDENTS TO DIAGNOSE & TREAT D *20, 10 R5
COOPERATIVE SPECIALIZED INFERTILITY RESEARCH CENTER PROGRAM *20, 10 R9
MINORITY ONCOLOGY LEADERSHIP ACADEMIC AWARD *20, 10 R12
NRSA INSTITUTIONAL TRAINING GRANTS IN MEDICAL REHABILITATION RESE *20, 13 R3
Type Size in PHS 398
TYPE SIZE IN PHS 398 APPLICATIONS 20, 05 N1
Upper GI Carcinoma
CLINICAL TREATMENT AND CORRELATES OF UPPER GI CARCINOMA 20, 09 E1
Urogenital System
BASIC & CLINICAL RESEARCH ON URINARY BLADDER & PELVIC MUSCULATURE *20, 04 R5
Urology
RESEARCH CENTER OF EXCELLENCE IN PEDIATRIC NEPHROLOGY AND UROLOGY *20, 04 R6
KIDNEY AND UROLOGY RESEARCH CENTERS *20, 05 R9
THE UROLOGICAL COMPLICATIONS OF DIABETES MELLITUS 20, 06 P2
TRANSGENIC, CHIMERIC, AND IN VITRO MODELS OF KIDNEY DISEASES 20, 12 P1
INTERSTITIAL CYSTITIS DATA BASE: CLINICAL CENTERS & DATA COORDIN *20, 13 R6
Vaccine
EVALUATION OF VACCINE PROPHYLAXIS AGAINST INFECTIOUS DISEASES IN $20, 05 R1
MATERNAL IMMUNIZATION TO PREVENT INFECTIOUS DISEASES IN NEONATES $20, 05 R3
NON-HUMAN PRIMATE MODEL TO STUDY VACCINES IN PREGNANT FEMALES AND $20, 07 R3
VACCINE PRODUCTION FACILITY $20, 09 R1
Viral Studies (Virology)
CHRONIC FATIGUE SYNDROME COOPERATIVE RESEARCH CENTERS *20, 06 R6
VACCINE PRODUCTION FACILITY $20, 09 R1
Women in Study Populations
NIH/ADAMHA POLICY CONCERNING INCLUSION OF WOMEN IN STUDY POPULATI 20, 06 N1
Women's Health Trial
WOMEN'S HEALTH TRIAL: FEASIBILITY IN MINORITY POPULATIONS - CLIN $20, 13 R1
WOMEN'S HEALTH TRIAL: MINORITIES - STATISTICAL & NUTRITION COORD $20, 13 R2
Workshop
NATIONAL WORKSHOPS ON "PROTECTION OF HUMAN SUBJECTS" 20, 01 N2
NATIONAL WORKSHOPS ON "PROTECTION OF HUMAN SUBJECTS" 20, 02 N2
NATIONAL WORKSHOPS ON "PROTECTION OF HUMAN SUBJECTS" 20, 03 N1
METHODS OF MOLECULAR MECHANICS AND DYNAMICS OF BIOPOLYMERS WORKSH 20, 04 N5
NATIONAL WORKSHOPS ON "PROTECTION OF HUMAN SUBJECTS" 20, 05 N3
NATIONAL WORKSHOPS ON "PROTECTION OF HUMAN SUBJECTS" 20, 06 N4
NATIONAL WORKSHOPS ON "PROTECTION OF HUMAN SUBJECTS" 20, 08 N1
NATIONAL WORKSHOPS ON "PROTECTION OF HUMAN SUBJECTS" 20, 09 N3
NATIONAL WORKSHOPS ON "PROTECTION OF HUMAN SUBJECTS" 20, 13 N1
World AIDS Foundation
WORLD AIDS FOUNDATION 20, 07 N2
WORLD AIDS FOUNDATION 20, 09 N1
$$MAIL END**************************************************************